These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7619970

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of chronic hepatitis B and C with alpha interferon].
    Hess G.
    Z Gastroenterol Verh; 1991 Mar; 26():149-51. PubMed ID: 1714130
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Results of the treatment of chronic hepatitis B with interferon alfa (wellferon)].
    Gładysz A, Mach G, Juszczyk J, Simon K, Machaj A, Halota W, Molin I, Zalewska M.
    Przegl Epidemiol; 1991 Mar; 45(4):321-3. PubMed ID: 1841410
    [No Abstract] [Full Text] [Related]

  • 5. [Favorable outcome in chronic active hepatitis caused by B virus in childhood].
    Cadrobbi P, Bortolotti F, Crivellaro C, Rugge M, Armigliato M, Realdi G, Bertaggia A.
    Minerva Pediatr; 1984 Jul 31; 36(13-14):685-9. PubMed ID: 6503897
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chronic type B hepatitis.
    Hoofnagle JH.
    Gastroenterology; 1983 Feb 31; 84(2):422-4. PubMed ID: 6848416
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients.
    Zielińska W, Korczak-Rogoń A, Paszkiewicz J, Kowalik M, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1996 Feb 31; 44(5-6):359-66. PubMed ID: 9017152
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally.
    Zielińska W, Paszkiewicz J, Korczak A, Własiuk M, Zółtowska A, Szutowicz A, Cummins JM, Georgiades JA.
    Arch Immunol Ther Exp (Warsz); 1993 Feb 31; 41(3-4):241-51. PubMed ID: 8129568
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The combined treatment with prednisolone and recombinant alpha 2-interferon of patients with chronic hepatitis B: the factors influencing the immune response].
    Fedorchenko SV, Vovk AD, Rybalko SL.
    Ter Arkh; 1994 Feb 31; 66(2):24-9. PubMed ID: 8160138
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Re-treatment with interferon-alpha in chronic hepatitis B and C virus infection].
    Teuber G, Dienes HP, Meyer zum Büschenfelde KH, Gerken G.
    Z Gastroenterol; 1995 Feb 31; 33(2):94-8. PubMed ID: 7725763
    [Abstract] [Full Text] [Related]

  • 16. [Leukinferon in the treatment of severe forms of acute hepatitis B].
    Botsvadze ESh, Kuznetsov VP, Gogichaĭshvili ShSh.
    Ter Arkh; 1989 Feb 31; 61(11):50-4. PubMed ID: 2633393
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of chronic B virus hepatitis with specific transfer factor.
    Mazzella G, Ronchi M, Villanova N, Mohamed AA, Pizza G, De Vinci C, Viza D, Roda E, Barbara L.
    J Exp Pathol; 1987 Feb 31; 3(4):421-3. PubMed ID: 3454802
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical course and outcome of acute hepatitis B in relation to the markers of the E system].
    Iushchuk ND, Shestakova IV, Klimova EA, Sergeeva NA, Malyshev NA, Braginskiĭ DM, Favorov MO.
    Ross Med Zh; 1992 Feb 31; (4):42-4. PubMed ID: 1521021
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.